Needham Company Earns FDA Approval for Rare Disease Treatment
October 13, 2025 • After more than 10 years of work developing the drug, Stealth BioTherapeutics looks to bring Forzinity to Barth syndrome patients. In...
October 13, 2025 • After more than 10 years of work developing the drug, Stealth BioTherapeutics looks to bring Forzinity to Barth syndrome patients. In...
